title: CX3CL1 in allergic diseases: not just a chemotactic molecule.
abstract: Allergic asthma and atopic dermatitis (AD) are two allergic diseases that are primarily driven by the activation of T helper (Th)2 cells. Th2 cells produce cytokines that directly contribute to the symptoms of these diseases. The recruitment and maintenance of Th2 cells into the target tissues are two key events in the pathogenesis of allergic asthma and AD. While migration is mediated by both chemokines and lipid mediators such as leukotrienes and prostaglandins, very little is known about the molecules involved in lymphocyte survival and maintenance in inflamed tissues. However, chemokines could also play a role in this phenomenon. An example of this could be illustrated by CX3CL1, also known as fractalkine. CX3CL1 is a chemokine that is upregulated in some inflammatory diseases including allergic pathologies and that was recently demonstrated to provide a survival signal upon binding to its unique receptor CX3CR1.
authors: Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université de Nice-Sophia Antipolis, Valbonne, France. julia@ipmc.cnrs.fr
authors: V
authors: V
authors: Julia
mesh_terms: D000818:Animals; D001249:Asthma / Q000276:immunology / Q000503:physiopathology; D054428:Chemokine CX3CL1 / Q000378:metabolism*; D002633:Chemotaxis / Q000502:physiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000503:physiopathology; D007249:Inflammation / Q000276:immunology / Q000503:physiopathology; D051379:Mice
chemical_list: C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1